Candriam S.C.A. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$5,905,000
-75.5%
604,379
-14.6%
0.04%
-76.8%
Q3 2021$24,061,000
-7.2%
708,1170.0%0.16%
-7.3%
Q2 2021$25,924,000
+167.7%
708,117
+300.8%
0.18%
+118.5%
Q1 2021$9,684,000
-3.9%
176,655
+0.0%
0.08%
+1.2%
Q4 2020$10,081,000
-21.2%
176,636
-29.2%
0.08%
-33.3%
Q3 2020$12,800,000
-14.9%
249,519
-0.9%
0.12%
-24.5%
Q2 2020$15,033,000
+1503200.0%
251,715
+1797864.3%
0.16%
Q1 2020$1,000140.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders